The ticket window is open again for space flights at Virgin Galactic, with prices starting at $450,000 a seat.

The space tourism company said Thursday it is making progress toward beginning revenue flights next year. It will sell single seats, package deals and entire flights.

Virgin Galactic announced the offerings as it reported Thursday that it lost $94 million in the second quarter on soaring costs for overhead and sales. The company posted revenue of $571,000, barely enough to cover one seat on a future flight.

The company’s most noteworthy recent achievement came last month after the quarter ended when founder Richard Branson and five crewmates soared to 53.5 miles (86 kilometers) above the New Mexico desert.

CEO Michael Colglazier said the company resumed sales on Thursday to take advantage of a surge in consumer interest after the flight by Branson, who beat rival billionaire Jeff Bezos and his Blue Origin ship into space by nine days.

The company based in Las Cruces, New Mexico, won regulatory approval in June to fly people into space.

Virgin Galactic said “early hand-raisers” will get first priority to book seats, and another list will be created for new customers.

The company’s next spaceflight is scheduled for late September in New Mexico with the Italian air force.

Virgin Galactic said it ended the quarter with cash and equivalents totaling $552 million.

The results were released after the stock market closed. The company's shares were up nearly 5% in after-hours trading.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More